Protein on GLP-1: How Much You Actually Need and Why It Matters

One of the most consistent side effects of GLP-1 therapy is also one of its main benefits: a significant reduction in appetite. You eat less, feel full faster, and have fewer food cravings.

But eating less also means taking in less protein, unless you are deliberate about it. And on GLP-1 therapy, protein intake matters more than at almost any other time.

Why protein is critical during GLP-1 treatment

When your body loses weight, it does not lose only fat. It also loses some muscle, how much depends largely on protein intake and physical activity.

Muscle mass matters for several reasons:

• Metabolic rate: muscle tissue burns more calories at rest than fat tissue. Less muscle means a slower metabolism, making long-term weight maintenance harder
• Strength and function: muscle loss accelerates with age and worsens mobility
• Body composition: people with higher muscle mass look and feel different from those who lost the same weight but with more muscle loss

In clinical trials, GLP-1 medications have been associated with some lean mass reduction alongside fat loss. In a body-composition substudy of the STEP 1 semaglutide trial, about 38% of the weight lost was lean mass (which includes water and organs, not only muscle). Low protein intake and little resistance exercise both make muscle loss more likely; the 2025 joint advisory notes that extra protein alone is probably not enough without strength training.

How much protein do you need?

Standard dietary guidelines recommend 0.8 g of protein per kg of body weight. But standard guidelines are set for sedentary adults in caloric balance, not for people in active weight loss on GLP-1 therapy.

Higher targets that have been proposed during active weight loss are:

1.2–1.6 g of protein per kg of body weight per day

The 2025 joint advisory points out that using your actual body weight can significantly overestimate needs in people with a higher body weight, and suggests an absolute target of 80–120 g per day may be easier to follow. It also advises against prolonged intake at or above 2 g/kg per day. If you have kidney disease, ask your doctor before increasing protein.

What that looks like in practice

At higher body weights these numbers may be more than you need; a dietitian can set a target based on adjusted body weight or lean mass.

When appetite is low and you are eating much less than usual, hitting 100 g or more of protein a day requires intentional planning.

The best protein sources for GLP-1 users

The most efficient protein sources, highest protein per calorie:

Animal sources (easiest to hit targets)

• Chicken breast: 31 g protein / 165 kcal per 100 g
• Tuna (canned in water): about 25 g protein / 116 kcal per 100 g
• Greek yoghurt (low-fat): 17 g protein / 100 kcal per 170 g serving
• Eggs: 6 g protein per egg, 78 kcal
• Cottage cheese: 25 g protein / 200 kcal per cup
• Salmon: 25 g protein / 175 kcal per 100 g
• Shrimp: 24 g protein / 99 kcal per 100 g

Plant-based sources

• Tofu (firm): 17 g protein / 144 kcal per 100 g
• Edamame: 18 g protein / 188 kcal per cup
• Lentils (cooked): 18 g protein / 230 kcal per cup
• Tempeh: about 20 g protein / 193 kcal per 100 g
• Black beans (cooked): 15 g protein / 227 kcal per cup

For when appetite is very low

• Whey protein isolate: 25–27 g protein per scoop, ~110 kcal
• Casein protein: 24 g per scoop, slower-digesting, good before sleep
• Plant protein blend (pea + rice): 20–25 g per scoop

Practical strategies for hitting protein targets

Protein first at every meal

Before eating carbohydrates or fats, eat your protein portion. When appetite fades quickly, you want protein to be what you prioritise, not what you skip.

Front-load protein in the day

GLP-1 users often find appetite is lower in the evening. Distributing protein across breakfast and lunch, rather than saving it for dinner, helps hit daily targets even when dinner feels unappealing.

Use a simple daily target, not per-meal tracking

If you aim for 30 g at each of three meals plus a 20–30 g protein shake, you reach 110–120 g without complex tracking.

Make it convenient

Keeping hard-boiled eggs, Greek yoghurt, cottage cheese, and pre-cooked chicken easily accessible reduces friction when appetite is low.

Protein and hair loss

Hair thinning (often telogen effluvium) is reported by a small share of people on GLP-1 medicines, and is mostly linked to rapid weight loss and eating much less overall. Hair is made largely of keratin, a protein, and very low intake of protein and other nutrients can contribute to shedding.

Eating enough protein and a varied diet is a sensible way to support hair during treatment. If shedding is heavy or lasts more than a few months, ask your doctor to check for other causes such as low iron or thyroid problems.

Tracking protein alongside your medication

If you are tracking weight and doses but not protein, you are missing a key variable. During weeks when hair loss increases or weight loss stalls, protein intake is often the first thing to check.

Keeping even a rough weekly protein log, not a detailed per-meal count, just a sense of whether you hit your target, gives you useful context when reviewing your progress.

Final takeaway

GLP-1 medications suppress appetite significantly, which reduces protein intake unless you are deliberate about it. Ask your clinician or dietitian for a personal protein target; many people aim for roughly 80–120 g a day, or 1.2–1.6 g per kg where that is appropriate. Prioritise protein at every meal, front-load it in the earlier part of the day, and use protein shakes on low-appetite days. Together with strength training, this helps preserve muscle and supports long-term weight maintenance.

Related Articles

• What to Eat While Taking Obeda
• GLP-1 Hair Loss: Why It Happens and What to Do
• GLP-1 Weight Loss Plateau: What to Do

Consult your healthcare provider about nutritional targets specific to your situation.

Consult your healthcare provider before starting any medication.

Sources

• MedlinePlus — semaglutide injection: https://medlineplus.gov/druginfo/meds/a618008.html
• CDC — healthy weight and growth: https://www.cdc.gov/healthy-weight-growth/index.html
• WHO — obesity and overweight: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• STEP 1 semaglutide trial — PubMed: https://pubmed.ncbi.nlm.nih.gov/33567185/
• Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society (2025): https://pmc.ncbi.nlm.nih.gov/articles/PMC12304835/